1 Min Read
March 6 (Reuters) - Teligent Inc
* Teligent Inc announces FDA approval of triamcinolone acetonide ointment usp, 0.5 pct
* Teligent Inc - expect to launch product in Q2 of 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.